Your browser doesn't support javascript.
loading
Alantolactone inhibits oesophageal adenocarcinoma cells through nuclear factor erythroid 2-related factor 2-mediated reactive oxygen species increment.
Chen, Jianhua; Zhang, Yunxiang; Huang, Rong; Cao, Lihua; Zhang, Ying; Lian, Maowei; Wang, Zuo; Jin, Jiajia; Tang, Chu; Chen, Tingting; Yan, Linli; Yu, Linze; Tian, Ruimin; Xiang, Xiaocong; Luo, Lijun; Yu, Chunlei.
Afiliação
  • Chen J; Institute of Materia Medica, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Zhang Y; School of Basic Medical Sciences & Forensic Medicine, North Sichuan Medical College, Nanchong, China.
  • Huang R; Medical imaging Key Laboratory of Sichuan Province, North Sichuan Medical College, Nanchong, China.
  • Cao L; Institute of Materia Medica, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Zhang Y; Institute of Materia Medica, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Lian M; Department of Anesthesiology, School of Clinical Medicine, North Sichuan Medical College, Nanchong, China.
  • Wang Z; Institute of Materia Medica, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Jin J; Institute of Tissue Engineering and Stem Cells, Cancer Biotherapy Key Laboratory of Nanchong, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, China.
  • Tang C; Institute of Materia Medica, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Chen T; Institute of Tissue Engineering and Stem Cells, Cancer Biotherapy Key Laboratory of Nanchong, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, China.
  • Yan L; Institute of Materia Medica, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Yu L; Institute of Tissue Engineering and Stem Cells, Cancer Biotherapy Key Laboratory of Nanchong, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, China.
  • Tian R; Institute of Materia Medica, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
  • Xiang X; Institute of Tissue Engineering and Stem Cells, Cancer Biotherapy Key Laboratory of Nanchong, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, China.
  • Luo L; Medical imaging Key Laboratory of Sichuan Province, North Sichuan Medical College, Nanchong, China.
  • Yu C; Department of Anesthesiology, School of Clinical Medicine, North Sichuan Medical College, Nanchong, China.
Basic Clin Pharmacol Toxicol ; 132(3): 253-262, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36507595
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Espécies Reativas de Oxigênio / Sesquiterpenos de Eudesmano Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Basic Clin Pharmacol Toxicol Assunto da revista: FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Espécies Reativas de Oxigênio / Sesquiterpenos de Eudesmano Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Basic Clin Pharmacol Toxicol Assunto da revista: FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China